| __timestamp | BioMarin Pharmaceutical Inc. | Eli Lilly and Company |
|---|---|---|
| Wednesday, January 1, 2014 | 751040000 | 19615600000 |
| Thursday, January 1, 2015 | 889895000 | 19958700000 |
| Friday, January 1, 2016 | 1116854000 | 21222100000 |
| Sunday, January 1, 2017 | 1313646000 | 22871300000 |
| Monday, January 1, 2018 | 1491212000 | 21493300000 |
| Tuesday, January 1, 2019 | 1704048000 | 22319500000 |
| Wednesday, January 1, 2020 | 1860455000 | 24539800000 |
| Friday, January 1, 2021 | 1846275000 | 28318400000 |
| Saturday, January 1, 2022 | 2096039000 | 28541400000 |
| Sunday, January 1, 2023 | 2419226000 | 34124100000 |
| Monday, January 1, 2024 | 2853915000 | 45042700000 |
Unveiling the hidden dimensions of data
In the competitive landscape of pharmaceuticals, revenue growth is a key indicator of success. Over the past decade, Eli Lilly and Company has consistently outperformed BioMarin Pharmaceutical Inc. in terms of revenue. From 2014 to 2023, Eli Lilly's revenue surged by approximately 74%, reaching a peak of $34.1 billion in 2023. In contrast, BioMarin's revenue grew by about 222%, yet it only reached $2.4 billion in the same year.
Eli Lilly's robust growth can be attributed to its strong portfolio of blockbuster drugs and strategic acquisitions. Meanwhile, BioMarin, known for its focus on rare diseases, has shown impressive growth rates, albeit from a smaller base. This comparison highlights the diverse strategies within the pharmaceutical industry and underscores the importance of scale and innovation in driving financial performance.
Revenue Insights: Eli Lilly and Company and GSK plc Performance Compared
Revenue Insights: Eli Lilly and Company and Novo Nordisk A/S Performance Compared
Eli Lilly and Company vs AbbVie Inc.: Annual Revenue Growth Compared
Eli Lilly and Company vs Regeneron Pharmaceuticals, Inc.: Examining Key Revenue Metrics
Breaking Down Revenue Trends: Eli Lilly and Company vs Amneal Pharmaceuticals, Inc.
Eli Lilly and Company or Veracyte, Inc.: Who Leads in Yearly Revenue?
Annual Revenue Comparison: Eli Lilly and Company vs ACADIA Pharmaceuticals Inc.
Eli Lilly and Company vs Xencor, Inc.: Examining Key Revenue Metrics
Revenue Showdown: Johnson & Johnson vs BioMarin Pharmaceutical Inc.
AstraZeneca PLC or BioMarin Pharmaceutical Inc.: Who Leads in Yearly Revenue?
Takeda Pharmaceutical Company Limited and BioMarin Pharmaceutical Inc.: A Comprehensive Revenue Analysis
BioMarin Pharmaceutical Inc. vs BioCryst Pharmaceuticals, Inc.: Examining Key Revenue Metrics